Mycenax Biotech Inc.

About Mycenax Biotech Inc.

Founded in 2001, Mycenax is a fully dedicated biologics CDMO offering one-stop services from development to commercial production, including cell line development (mammalian, microbial), process development, formulation development, analytical development, GMP production, and aseptic fill/ finish.

We have extensive experience in developing biologic products for our clients worldwide, ranging from recombinant protein, fusion protein, monoclonal antibody, antibody-drug conjugate (ADC), and gene/cell therapy products. The most noteworthy is that we provide our clients with customized and efficient services.

  • TW
  • 2022
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022